S. 839 (112th): Combating Designer Drugs Act of 2011


Apr 14, 2011
112th Congress, 2011–2013

Died in a previous Congress

This bill was introduced on July 28, 2011, in a previous session of Congress, but was not enacted.


Amy Klobuchar

Senator from Minnesota



Read Text »
Last Updated: Jul 28, 2011
Length: 4 pages

About the bill

Full Title

A bill to ban the sale of certain synthetic drugs.

Summary (CRS)

7/28/2011--Reported to Senate without amendment.Combating Designer Drugs Act of 2011 - Amends the Controlled Substances Act to include as a Schedule I controlled substance any material, compound, mixture, or preparation ... Read more >

The bill’s title was written by its sponsor.


Apr 14, 2011

This is the first step in the legislative process.

Jul 28, 2011
Reported by Committee

A committee has issued a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee.

This is a Senate bill in the United States Congress (indicated by the “S.” in “S. 839”). A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.


5 cosponsors (3D, 2R) (show)
Committee Assignments

The committee chair determines whether a bill will move past the committee stage.


There have been no roll call votes related to this bill.

Subject Areas
Find Similar Bills

Search for similar bills.

Links & tools

Primary Source

THOMAS.gov (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here. Data comes via the congress project.


Click a format for a citation suggestion: